While our furry companions may live longer, they also face a higher risk of developing harmful conditions, like "dog dementia ...

Coconut oil has gained immense popularity in recent years, touted as a versatile superfood with a wide range of health benefits. Extracted from the meat of mature coconuts, this tropical oil is rich ...

Nov 24 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Monday that two late-stage trials testing an older oral version of its semaglutide drug failed to meet their main goal. Shares in Novo ...

Top-line results from two large clinical trials by Novo Nordisk, the company behind Ozempic and Wegovy, found oral semaglutide failed to slow down Alzheimer's progression Endocrinologist Daniel ...

Lilly’s (LLY) recent climb to reach a $1T market cap will come under scrutiny in the coming days when Novo Nordisk (NVO) posts late-stage trial data showing how Rybelsus, its diabetes pill containing ...

NEW ORLEANS — When added to standard lipid-lowering therapy, olezarsen, a drug approved in 2024 for patients with familial chylomicronemia syndrome, significantly lowered triglycerides and reduced the ...

"I just know that my brain's not right," said Carrie Richardson, 44. "And so, I hate it. I just want it to be normal." At 41, Carrie developed early-onset Alzheimer's disease. The condition is caused ...

CHICAGO, Nov 8 (Reuters) - A single infusion of CRISPR Therapeutics' (CRSP.BN), opens new tab experimental gene therapy was safe and reduced levels of harmful LDL cholesterol and triglycerides by half ...

NEW ORLEANS, LA—DR10624, an investigational drug designed to reduce triglycerides among patients with severely high levels, performed well in a phase II trial, researchers announced today at the ...

Denny's, the breakfast chain known for classic diner food and its Grand Slam Breakfast, is going private in a $620 million deal orchestrated by a group of investors. The deal, announced Monday, values ...